Patient Controlled Analgesia (PCA): Intravenous versus Epidural Morphine in Morbidly Obese Patients undergoing Laparoscopic Sleeve Gastrectomy - Trial PACTR202103915814652
Access comprehensive clinical trial information for PACTR202103915814652 through Pure Global AI's free database. This Phase 2 trial is sponsored by Nadia M. Bahgat and is currently Recruiting. The study focuses on Surgery; Anaesthesia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Nadia M. Bahgat
Timeline & Enrollment
Phase 2
Mar 13, 2021
Jan 01, 1900
Summary
Postoperative complications in patients with morbid obesity have been consistently linked to increasing body mass index (BMI), and the use of opioids has been found to have strong association in precipitating the same. Patients with morbid obesity show unique physiological alterations that modify both pharmacokinetics and pharmacodynamics of opioids eventually predisposing them to increased sensitivity towards unwanted sedative effect.Bearing these concerns in mind it is not uncommon to undertreat perioperative pain in patients with morbid obesity. Instead of relying primarily upon opioids, one must use combinations of analgesics that act by different mechanisms and add to analgesic efficacy rather than adverse effects. In this study we will compare the use of Patient Controlled Analgesia (PCA): Intravenous versus Epidural Morphine in Morbidly Obese Patients undergoing Laparoscopic Sleeve Gastrectomy
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202103915814652
Non-Device Trial